[go: up one dir, main page]

RU2006113391A - METHOD FOR TREATING A PERSISTENT FORM OF ATRIAL FIBRILLATION - Google Patents

METHOD FOR TREATING A PERSISTENT FORM OF ATRIAL FIBRILLATION Download PDF

Info

Publication number
RU2006113391A
RU2006113391A RU2006113391/14A RU2006113391A RU2006113391A RU 2006113391 A RU2006113391 A RU 2006113391A RU 2006113391/14 A RU2006113391/14 A RU 2006113391/14A RU 2006113391 A RU2006113391 A RU 2006113391A RU 2006113391 A RU2006113391 A RU 2006113391A
Authority
RU
Russia
Prior art keywords
treating
atrial fibrillation
persistent form
persistent
daily dose
Prior art date
Application number
RU2006113391/14A
Other languages
Russian (ru)
Other versions
RU2320328C2 (en
Inventor
Оксана Олеговна Мурашкина (RU)
Оксана Олеговна Мурашкина
Original Assignee
ГОУ ВПО Смоленска государственна медицинска академи Федерального агентства по здравоохранению исоциальному развитию (RU)
ГОУ ВПО Смоленская государственная медицинская академия Федерального агентства по здравоохранению и социальному развитию
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ГОУ ВПО Смоленска государственна медицинска академи Федерального агентства по здравоохранению исоциальному развитию (RU), ГОУ ВПО Смоленская государственная медицинская академия Федерального агентства по здравоохранению и социальному развитию filed Critical ГОУ ВПО Смоленска государственна медицинска академи Федерального агентства по здравоохранению исоциальному развитию (RU)
Priority to RU2006113391/14A priority Critical patent/RU2320328C2/en
Publication of RU2006113391A publication Critical patent/RU2006113391A/en
Application granted granted Critical
Publication of RU2320328C2 publication Critical patent/RU2320328C2/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Claims (1)

Способ лечения персистирующей формы фибрилляции предсердий, включающий применение традиционных антиаритмических препаратов: амиодарона в поддерживающей суточной дозе 200 мг по пятидневной схеме и бисопролола 2,5 мг ежедневно, отличающийся тем, что дополнительно одновременно с ними применяют аторвастатин в суточной дозе 10 мг постоянно.A method of treating a persistent form of atrial fibrillation, including the use of traditional antiarrhythmic drugs: amiodarone in a maintenance daily dose of 200 mg according to a five-day regimen and bisoprolol 2.5 mg daily, characterized in that atorvastatin is also used at the same time in a daily dose of 10 mg constantly.
RU2006113391/14A 2006-04-21 2006-04-21 Method for treating persisting form of atrial fibrillation RU2320328C2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RU2006113391/14A RU2320328C2 (en) 2006-04-21 2006-04-21 Method for treating persisting form of atrial fibrillation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU2006113391/14A RU2320328C2 (en) 2006-04-21 2006-04-21 Method for treating persisting form of atrial fibrillation

Publications (2)

Publication Number Publication Date
RU2006113391A true RU2006113391A (en) 2007-11-20
RU2320328C2 RU2320328C2 (en) 2008-03-27

Family

ID=38958908

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2006113391/14A RU2320328C2 (en) 2006-04-21 2006-04-21 Method for treating persisting form of atrial fibrillation

Country Status (1)

Country Link
RU (1) RU2320328C2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2707263C2 (en) * 2018-05-11 2019-11-25 Федеральное государственное бюджетное образовательное учреждение дополнительного профессионального образования "Российская медицинская академия непрерывного профессионального образования" Министерства здравоохранения Российской Федерации (ФГБОУ ДПО РМАНПО Минздрава России) Method for studying heart rate variability with underlying antiarrhythmic therapy

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE482698T1 (en) * 2003-06-18 2010-10-15 Inst Cardiologie De Montreal M PREVENTING Atrial Fibrillation (AF) WITH THE USE OF STATIN
RU2256450C1 (en) * 2004-03-04 2005-07-20 Лазебник Леонид Борисович Method for treating atrial fibrillations
RU2268713C1 (en) * 2005-01-31 2006-01-27 Государственное образовательное учреждение высшего профессионального образования Казанский государственный медицинский университет Method for treating atrial fibrillation in case of myocardial infarction

Also Published As

Publication number Publication date
RU2320328C2 (en) 2008-03-27

Similar Documents

Publication Publication Date Title
Volgman et al. Women with atrial fibrillation: greater risk, less attention
FI2498756T4 (en) Tablet formulations of neratinib maleate
FI4056176T3 (en) Methods of reducing the risk of cardiovascular events in a subject
EA201100756A1 (en) METHOD OF TREATMENT OR PREVENTION OF THROMBOSIS BY USING DAGIGATRAN ETHESYLATE OR ITS SALT WITH AN IMPROVED SAFETY PROFILE AS COMPARED TO STANDARD TREATMENT WARFARIN
NO20071974L (en) Platelet-derived growth factor composition and methods for its use
EA201100755A1 (en) METHOD OF TREATMENT OR PREVENTION OF THROMBOSIS BY USING DABIGATRANE ETHSYLATE OR ITS SALT WITH IMPROVED EFFICIENCY IN COMPARISON WITH STANDARD TREATMENT WARFARIN
IL195472A0 (en) Use of allopurinol for the treatment of palmar plantar erythrodysesthesia
WO2009099553A3 (en) Use of kinase inhibitor in treatment of atherosclerosis
WO2012021818A3 (en) Ggf2 and methods of use
WO2015038552A3 (en) Aspirin formulation for increased efficacy
RU2015109566A (en) NEW EXTRACTS FROM CYNARA SCOLYMUS, COFFEA spp. AND OLEA EUROPAEA FOR THE TREATMENT OF A METABOLIC SYNDROME
PE20110706A1 (en) USE OF DRONEDARONE FOR THE PREPARATION OF A MEDICATION FOR THE PREVENTION OF STROKE OR TRANSITORY ISCHEMIC ATTACK
JP2005527551A5 (en)
DE602007011316D1 (en) PHARMACEUTICAL COMPOSITION WITH ANTIPSYCHOTIC, ANTIDEPRESSIVE OR ANTIEPILEPTIC EFFECT WITH REDUCED SIDE EFFECTS
RU2006113391A (en) METHOD FOR TREATING A PERSISTENT FORM OF ATRIAL FIBRILLATION
NZ592613A (en) Method for treating or preventing thrombosis using >150 mg to 300 mg b.i.d. of dabigatran etexilate or a salt thereof with improved efficacy over conventional warfarin therapy
WO2009133470A3 (en) Use of dronedarone alone or in combination for preparing a medicament for the treatment of patients with arrhythmia and having an increase of creatinine level
MXPA06012206A (en) Ozonidzed pharmaceutical composition and method.
NZ595469A (en) Sublingual spray formulation comprising dihydroartemesinin
JP2005501108A5 (en)
MXPA04005033A (en) Pharmaceutical composition comprising a combination of metformin and a 4-oxobutanoic acid, and the use thereof for treating diabetes.
RU2011130246A (en) PHYTOESTROGENIC COMPOSITIONS FOR PREVENTING OR TREATING SYMPTOMS CONNECTED WITH MENOPAUSE
JP2010523563A5 (en)
ATE546137T1 (en) PHARMACEUTICAL COMPOSITIONS FOR TREATING WARTS
PE20040748A1 (en) COMBINATIONS OF EPINASTINE, PSEUDOEPHEDRINE AND METHYLEPHEDRINE AS NEW PHARMACEUTICAL FORMULATIONS

Legal Events

Date Code Title Description
MM4A The patent is invalid due to non-payment of fees

Effective date: 20080422